A mill investment announcement contains several different dates and quantities. The capital budget, target completion and actual supply interruption are not interchangeable. Georgia-Pacific’s Palatka tissue-machine announcement should not be recast as containerboard expansion or a confirmed supply gap. The accompanying images show generic equipment, not the real mill.
Field problem
In its October 29 release, Georgia-Pacific says it will invest approximately $150 million to replace the No. 4 paper machine, installed in 1980, at its Palatka, Florida mill. The machine makes paper for Angel Soft bath tissue. Work has begun, with completion expected in the second quarter of 2028.
That is a company plan, not a completed rebuild. The release does not provide a specific shutdown start date or duration, monthly lost output, or customer-by-customer delivery adjustments.
Evidence to check
The company names safety, reliability, quality and productivity as reasons for the investment and says it aims to preserve existing production while improving manufacturing capability. Describing it as a new containerboard line would confuse both the product and the project. The October 29 PULPAPERnews report relays the announcement, but a quantified downtime or volume impact requires later company information.
Practical deliverable
Tissue buyers can ask suppliers for (1) the planned No. 4 stop and restart dates, (2) alternate machine capacity, (3) quality-change approval timing, and (4) safety-stock and delivery-change notification rules. This is a planning checklist, not a claim that disruption has already occurred.
When to hold application
Do not forecast a shortage or price effect numerically before shutdown duration and actual output are disclosed. Do not use a bath-tissue-machine project as direct evidence of corrugated board or paperboard capacity growth.
About the Author
PackingMaster edits PaperPackLog’s coverage of paper-packaging markets and technical application conditions.